|
|
||||||||
Address correspondence to Hirotaka Oishi, M.D., Ph.D., Ariake Sea Research Project, Saga University, 5-1-1, Nabeshima, Saga City, Saga, 849-8501, Japan; tel 81 952 34 2373; fax 81 952 34 2056; e-mail ooishih{at}cc.saga-u.ac.jp.
| Abstract |
|---|
|
|
|---|
Keywords: Vibrio vulnificus, chromogenic substrate culture plate, necrotizing fasciitis, sepsis
| Introduction |
|---|
|
|
|---|
Fatal V. vulnificus infection is relatively rare, but many cases of this infection have been reported since 1980 in the southwestern prefectures of Japan. In a previous study, we found that approximately 40% of patients in Japan were reported from hospitals around the Ariake Sea [3]. In particular, the Saga prefecture (located near the deepest part of the Ariake Sea) was the location of more than 30 patients. A quick and easy isolation method that can be used to detect V. vulnificus bacteria in various environments, such as in marine waters and in seafood, is necessary.
We report the development of a modified agar plate containing a chromogenic substrate for the identification of Vibrios. This culture agar plate (Chromochecker Vibrio Agar-1; CVA-1) can readily distinguish between pathogenic Vibrios, including V. vulnificus, according to colony characteristics and chromatic differences.
| Materials and Methods |
|---|
|
|
|---|
Standard culture methods were used. Bacterial medium concentration was adjusted to McFarland No. 1. Plated bacteria were cultured for 18 – 24 hr at 35 °C under aerobic conditions. Results were assessed according to colony growth, color, and form. All isolates were identified by biochemical property using the VITEK II automated system (Japan bioMerieux, Tokyo, Japan) or the Phoenix automated system (Nippon Becton Dickinson, Tokyo, Japan).
To validate the performance of CVA-1 for the identification of V. vulnificus, we compared CVA-1 results with those of the biochemical identification system. The determination of the color and form of colonies on CVA-1 was performed by one medical technologist. One hundred four strains of V. vulnificus (22 from clinical sources, 2 from fish, 31 from oyster shells, and 49 from seawater), which had previously ben identified by the biochemical identification system, were inoculated onto CVA-1.
We also investigated bacterial samples from seawater in the Ariake Sea from July to March. Of 207 samples that formed colonies on CVA-1, 51 suspected to be V. vulnificus were identified by the biochemical identification system.
To determine the ability of CVA-1 to differentiate bacteria that cause necrotizing fasciitis, the following 8 strains were examined: V. vulnificus, Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, Aeromonas hydrophila, and Streptococcus pneumoniae. V. vulnificus and the seven strains of non-Vibrio bacteria were obtained from patients with primary septicemia and necrotizing fasciitis at our hospital. We compared colony growth and color in 3 agar culture plates (CVA-1, blood agar, and chocolate agar). All of the plates were purchased from Eiken Chemical Co., Ltd. In addition, in order to examine the usefulness of the CVA-1 plate in the clinical setting, we used this plate in hospitals to identify bacteria in patients with necrotizing fasciitis.
We also examined the growth of Vibrio species on 3 different culture plates for Vibrio detection. We examined colony growth and color on CVA-1, thiosulfate, citrate, bile salts, and sucrose (TCBS) agar (Eiken Chemical Co., Ltd), and CHROM agar Vibrio (Kanto Chemical Co., Tokyo, Japan). The following 8 Vibrio species were examined: V. vulnificus (Eiken catalog no. EKN-6543), V. parahaemolyticus (EKN-234), V. alginolyticus (EKN-Toh2), V. cholerae (EKN-313), V. mimicus (EKN-915), and V. fluvialis (EKN-914).
| Results |
|---|
|
|
|---|
|
Fifty-one isolates of suspected V. vulnificus grown on CVA-1 were subsequently identified with the biochemical identification system. Thirty-six of the colonies (70.6%) were identified as V. vulnificus. The other 15 samples were identified as Aeromonas salmonicida (n = 3), Pseudomonas stutzeri (n = 1), Photobacterium damselae (n = 1), Sphingomonas paucimobilis (n = 9), or V. parahaemolyticus (n = 1).
Identification of bacteria causing necrotizing fasciitis.
Eight bacterial strains that cause necrotizing fasciitis were cultured on blood agar (Fig. 2A
), chocolate agar (Fig. 2B
), and CVA-1 (Fig. 2C
). All of the strains, with the exception of H. influenzae, grew on blood agar, and all of the strains grew on chocolate agar. However, only V. vulnificus grew on CVA-1.
|
Growth of Vibrio species on different culture plates.
Eight Vibrio species were cultured on CVA-1, TCBS agar, and CHROM agar Vibrio plates (Fig. 3
). Colony size was similar on the 3 types of plates. On CVA-1, the colors and forms were as follows: V. vulnificus, navy blue and flat; V. parahaemolyticus, light blue and mucoid; V. cholerae, brown and flat; V. alginolyticus, yellow and mucoid; V. mimicus, light blue and flat; and V. fluvialis, light yellow and flat. Each Vibrio species was readily differentiated from the other Vibrio strains on CVA-1.
|
| Discussion |
|---|
|
|
|---|
Necrotizing fasciitis was first described as a life-threatening infection by Meleney in 1924 [4]. Progression, particularly in cases with V. vulnificus infection, is rapid, and the mortality rate is extremely high [5,6]. To decrease morbidity and mortality associated with severe soft-tissue damage in patients with compromised conditions, preventive measures should be taken, for example, education of high-risk individuals. In addition, early identification of the disease, aggressive and appropriate antibiotic therapy, aggressive debridement, and support care are necessary. One surgical option for the treatment of necrotizing fasciitis is amputation. However, amputation in the absence of identification of the pathogen would be inappropriate.
Our results show that CVA-1 can be used to identify V. vulnificus among several bacteria species that cause necrotizing fasciitis. In the present case of necrotizing fasciitis, V. vulnificus was identified on CVA-1 approximately 12 hr after hospital admission. Biochemical identification with systems, such as the VITEK II or Phoenix system after agar plate culture and colony isolation, is the standard method for the identification of bacterial species. However, this method requires 48 hr or longer.
Another advantage of CVA-1 is the detection of pathogenic Vibrio spp. We found that Vibrio spp. grow on CVA-1 as well as other commercial culture plates and can be readily differentiated from each other. V. parahaemolyticus is one of the most important causative organisms of food poisoning in Japan, and V. cholerae is an important pathogen in the tropical world, particularly in Southeast Asia, India, Bangladesh, and Africa. Although definitive identification requires a biochemical identification system or genetic screening, CVA-1 can provide rapid first-pass screening and does not require expensive laboratory equipment or complicated experimental procedures. CVA-1 is useful not only for the detection of V. vulnificus but also for other Vibrio species. We were able to detect the presence of pathogenic Vibrios in seawater with CVA-1. This has resulted in the distribution of CVA-1 to medical institutions in an attempt to prevent future outbreaks.
In conclusion, we have described a rapid and easy -to-use culture plate system for the identification of Vibrio spp. CVA-1 plates may be useful in various scientific applications, such as marine environmental monitoring, food hygiene, early clinical diagnosis in hospitals, and in preventive medicine, particularly in developing countries.
| Acknowledgment |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Ge and J. Meng Advanced Technologies for Pathogen and Toxin Detection in Foods: Current Applications and Future Directions Journal of Laboratory Automation, August 1, 2009; 14(4): 235 - 241. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |